Raloxifene Inhibits Estrogen-induced Up-regulation of Telomerase Activity in a Human Breast Cancer Cell Line

This publication has 46 references indexed in Scilit:

• Overview of the main outcomes in breast-cancer prevention trials
  The Lancet, 2003
• Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells
  Oncogene, 2002
• Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
  The Lancet, 1998
• Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
  The Lancet, 1998
• Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo
  Journal of Biological Chemistry, 1997
• Tamoxifen in the Treatment of Recurrent Ovarian Carcinoma
  International Journal of Gynecologic Cancer, 1997
• A survey of telomerase activity in human cancer
  Published by Elsevier ,1997
• Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary Report
  Gynecologic Oncology, 1996
• The Role of Estrogen in Mammary Carcinogenesis^a
  Annals of the New York Academy of Sciences, 1995
• Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
  Science, 1994